890 related articles for article (PubMed ID: 29254310)
1. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
Chen CY; Chen J; Xia CC; Huang ZX; Song B
J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
[TBL] [Abstract][Full Text] [Related]
2. Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with T1 mapping predicts the degree of differentiation in hepatocellular carcinoma.
Peng Z; Jiang M; Cai H; Chan T; Dong Z; Luo Y; Li ZP; Feng ST
BMC Cancer; 2016 Aug; 16():625. PubMed ID: 27520833
[TBL] [Abstract][Full Text] [Related]
3. Assessing liver function in patients with HBV-related HCC: a comparison of T₁ mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI.
Ding Y; Rao SX; Chen C; Li R; Zeng MS
Eur Radiol; 2015 May; 25(5):1392-8. PubMed ID: 25523455
[TBL] [Abstract][Full Text] [Related]
4. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
[TBL] [Abstract][Full Text] [Related]
6. Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.
Wu JW; Yu YC; Qu XL; Zhang Y; Gao H
World J Gastroenterol; 2018 Jan; 24(3):415-423. PubMed ID: 29391764
[TBL] [Abstract][Full Text] [Related]
7. Measuring hepatic functional reserve using T1 mapping of Gd-EOB-DTPA enhanced 3T MR imaging: A preliminary study comparing with
Nakagawa M; Namimoto T; Shimizu K; Morita K; Sakamoto F; Oda S; Nakaura T; Utsunomiya D; Shiraishi S; Yamashita Y
Eur J Radiol; 2017 Jul; 92():116-123. PubMed ID: 28624009
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of combined Gd-EOB-DTPA and gadobutrol magnetic resonance imaging for the prediction of hepatocellular carcinoma grading.
Schelhorn J; Best J; Dechêne A; Göbel T; Bertram S; Lauenstein T; Kinner S
Acta Radiol; 2016 Aug; 57(8):932-8. PubMed ID: 26586852
[TBL] [Abstract][Full Text] [Related]
9. The value of the signal intensity of peritumoral tissue on Gd-EOB-DTPA dynamic enhanced MRI in assessment of microvascular invasion and pathological grade of hepatocellular carcinoma.
Wang LL; Li JF; Lei JQ; Guo SL; Li JK; Xu YS; Dou Y
Medicine (Baltimore); 2021 May; 100(20):e25804. PubMed ID: 34011043
[TBL] [Abstract][Full Text] [Related]
10. Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.
Fan Y; Yu Y; Hu M; Wang X; Du M; Guo L; Hu C
Br J Radiol; 2021 Mar; 94(1119):20200950. PubMed ID: 33417489
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Gd-EOB-DTPA-Enhanced MRI for the Expression of Ki67 and Microvascular Density in Hepatocellular Carcinoma.
Chen Y; Qin X; Long L; Zhang L; Huang Z; Jiang Z; Li C
J Magn Reson Imaging; 2020 Jun; 51(6):1755-1763. PubMed ID: 31675163
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
Cui E; Long W; Luo L; Hu M; Huang L; Chen X
Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
[TBL] [Abstract][Full Text] [Related]
13. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
Li X; Li C; Wang R; Ren J; Yang J; Zhang Y
PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904
[TBL] [Abstract][Full Text] [Related]
14. Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis.
Pan J; Li W; Gu L; Liu C; Zhang K; Hong G
Eur Radiol; 2022 Nov; 32(11):7883-7895. PubMed ID: 35579711
[TBL] [Abstract][Full Text] [Related]
15. [The predictive value of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced MRI imaging features combined with quantitative parameters for the pathologic grading of hepatocellular carcinoma].
Hu MJ; Yu YX; Fan YF; Jiang YM; Hu S; Wang XM; Hu CH
Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1299-1304. PubMed ID: 32375436
[No Abstract] [Full Text] [Related]
16. Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic.
Zhou ZP; Long LL; Qiu WJ; Cheng G; Huang LJ; Yang TF; Huang ZK
Abdom Radiol (NY); 2017 Sep; 42(9):2272-2278. PubMed ID: 28396918
[TBL] [Abstract][Full Text] [Related]
17. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and Prognostication of Gd-EOB-DTPA MRI and CT in Patients With Macrotrabecular-Massive Hepatocellular Carcinoma.
Cheng J; Li X; Wang L; Chen F; Li Y; Zuo G; Pei M; Zhang H; Yu L; Liu C; Wang J; Han Q; Cai P; Li X
J Magn Reson Imaging; 2024 Jun; 59(6):2071-2081. PubMed ID: 37840197
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies.
Li J; Wang J; Lei L; Yuan G; He S
Eur Radiol; 2019 Dec; 29(12):6519-6528. PubMed ID: 31250172
[TBL] [Abstract][Full Text] [Related]
20. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.
Auer TA; Walter-Rittel T; Geisel D; Schöning W; Schmelzle M; Müller T; Sinn B; Denecke T; Hamm B; Fehrenbach U
BMC Med Imaging; 2021 Feb; 21(1):28. PubMed ID: 33588783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
